| 0 |
BILE ACIDS ABNORMAL |
8 |
0.3636 |
| 1 |
BILE ACIDS INCREASED |
53 |
0.2994 |
| 2 |
ALAGILLE SYNDROME |
3 |
0.2308 |
| 3 |
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS |
1 |
0.0714 |
| 4 |
LIPOPROTEIN ABNORMAL |
1 |
0.0667 |
| 5 |
PIERCING ASSOCIATED COMPLICATION |
1 |
0.0556 |
| 6 |
VITAMIN E DEFICIENCY |
2 |
0.0500 |
| 7 |
RENAL AND LIVER TRANSPLANT |
1 |
0.0500 |
| 8 |
TOTAL BILE ACIDS INCREASED |
7 |
0.0479 |
| 9 |
DUODENAL VARICES |
1 |
0.0417 |
| 10 |
XANTHOMA |
8 |
0.0396 |
| 11 |
FEMORAL ANTEVERSION |
1 |
0.0323 |
| 12 |
NEONATAL DYSPNOEA |
3 |
0.0316 |
| 13 |
CHOLESTATIC PRURITUS |
1 |
0.0312 |
| 14 |
LIVER TRANSPLANT |
103 |
0.0283 |
| 15 |
TRANSPLANT EVALUATION |
14 |
0.0276 |
| 16 |
BILIARY TRACT OPERATION |
2 |
0.0230 |
| 17 |
VITAMIN A INCREASED |
1 |
0.0200 |
| 18 |
VITAMIN E DECREASED |
1 |
0.0189 |
| 19 |
MYRINGOTOMY |
1 |
0.0185 |
| 20 |
ANORECTAL MALFORMATION |
1 |
0.0179 |
| 21 |
BLOOD BILIRUBIN |
1 |
0.0149 |
| 22 |
CONGENITAL ABSENCE OF BILE DUCTS |
1 |
0.0147 |
| 23 |
VIRAL CARDIOMYOPATHY |
1 |
0.0127 |
| 24 |
ROSEOLA |
1 |
0.0123 |
| 25 |
BLADDER TRABECULATION |
1 |
0.0123 |
| 26 |
INTRACARDIAC PRESSURE INCREASED |
1 |
0.0114 |
| 27 |
VITAMIN K DECREASED |
1 |
0.0106 |
| 28 |
VITAMIN K DEFICIENCY |
4 |
0.0100 |
| 29 |
VITAMIN A DEFICIENCY |
1 |
0.0098 |
| 30 |
FLUID INTAKE RESTRICTION |
1 |
0.0091 |
| 31 |
BILE ACID MALABSORPTION |
2 |
0.0071 |
| 32 |
LIMB FRACTURE |
1 |
0.0067 |
| 33 |
TEETHING |
2 |
0.0067 |
| 34 |
FEEDING INTOLERANCE |
3 |
0.0067 |
| 35 |
SHOULDER DYSTOCIA |
1 |
0.0066 |
| 36 |
VITAMIN A DECREASED |
1 |
0.0065 |
| 37 |
FAECES PALE |
14 |
0.0063 |
| 38 |
GROWTH FAILURE |
2 |
0.0058 |
| 39 |
MECONIUM IN AMNIOTIC FLUID |
2 |
0.0057 |
| 40 |
BILIRUBIN CONJUGATED INCREASED |
13 |
0.0056 |
| 41 |
ADENOIDECTOMY |
2 |
0.0052 |
| 42 |
BLOOD BILIRUBIN DECREASED |
3 |
0.0049 |
| 43 |
SUBCAPSULAR RENAL HAEMATOMA |
1 |
0.0047 |
| 44 |
MOYAMOYA DISEASE |
1 |
0.0046 |
| 45 |
ARTERIAL REPAIR |
1 |
0.0046 |
| 46 |
SOFT TISSUE MASS |
2 |
0.0043 |
| 47 |
BLOOD CHOLINESTERASE DECREASED |
1 |
0.0036 |
| 48 |
OSTEOMYELITIS BACTERIAL |
1 |
0.0036 |
| 49 |
GROIN INFECTION |
2 |
0.0036 |
| 50 |
AVULSION FRACTURE |
1 |
0.0035 |
| 51 |
EAR TUBE INSERTION |
1 |
0.0034 |
| 52 |
NEONATAL ASPIRATION |
1 |
0.0030 |
| 53 |
CHOLURIA |
1 |
0.0029 |
| 54 |
VIRAL DIARRHOEA |
1 |
0.0029 |
| 55 |
FAECAL OCCULT BLOOD POSITIVE |
1 |
0.0028 |
| 56 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
2 |
0.0028 |
| 57 |
FEEDING TUBE USER |
1 |
0.0027 |
| 58 |
EAR OPERATION |
1 |
0.0027 |
| 59 |
SPLENIC LESION |
1 |
0.0027 |
| 60 |
SUICIDE THREAT |
1 |
0.0026 |
| 61 |
PULMONARY ARTERY STENOSIS |
1 |
0.0026 |
| 62 |
OCULAR ICTERUS |
11 |
0.0025 |
| 63 |
VESICOURETERIC REFLUX |
1 |
0.0025 |
| 64 |
BLOOD BILIRUBIN INCREASED |
64 |
0.0024 |
| 65 |
BLOOD ALBUMIN INCREASED |
2 |
0.0022 |
| 66 |
PRIMARY BILIARY CHOLANGITIS |
1 |
0.0021 |
| 67 |
ELECTROLYTE DEPLETION |
1 |
0.0020 |
| 68 |
HEPATIC ADENOMA |
1 |
0.0019 |
| 69 |
EXPULSION OF MEDICATION |
1 |
0.0019 |
| 70 |
MOLLUSCUM CONTAGIOSUM |
1 |
0.0019 |
| 71 |
PORTAL HYPERTENSIVE GASTROPATHY |
1 |
0.0018 |
| 72 |
VACCINATION SITE PAIN |
1 |
0.0017 |
| 73 |
ROTAVIRUS INFECTION |
1 |
0.0017 |
| 74 |
OESOPHAGEAL IRRITATION |
1 |
0.0017 |
| 75 |
AMBLYOPIA |
1 |
0.0017 |
| 76 |
JAUNDICE |
44 |
0.0016 |
| 77 |
JAUNDICE NEONATAL |
3 |
0.0016 |
| 78 |
ABDOMINAL COMPARTMENT SYNDROME |
1 |
0.0016 |
| 79 |
SCRATCH |
16 |
0.0015 |
| 80 |
HYPOVITAMINOSIS |
2 |
0.0015 |
| 81 |
BRONCHITIS VIRAL |
1 |
0.0015 |
| 82 |
HEPATIC FIBROSIS |
5 |
0.0015 |
| 83 |
NEONATAL ASPHYXIA |
1 |
0.0014 |
| 84 |
PRODUCT DISPENSING ISSUE |
6 |
0.0014 |
| 85 |
NASAL INJURY |
1 |
0.0014 |
| 86 |
OESOPHAGEAL VARICES HAEMORRHAGE |
3 |
0.0014 |
| 87 |
GROWTH RETARDATION |
4 |
0.0014 |
| 88 |
GASTROINTESTINAL SURGERY |
1 |
0.0013 |
| 89 |
PORTAL HYPERTENSION |
4 |
0.0013 |
| 90 |
GALLBLADDER POLYP |
1 |
0.0013 |
| 91 |
LABORATORY TEST INTERFERENCE |
1 |
0.0013 |
| 92 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
28 |
0.0013 |
| 93 |
PNEUMONIA MYCOPLASMAL |
1 |
0.0013 |
| 94 |
PULMONARY VALVE STENOSIS |
1 |
0.0013 |
| 95 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
31 |
0.0012 |
| 96 |
VACCINATION COMPLICATION |
1 |
0.0012 |
| 97 |
TYMPANIC MEMBRANE PERFORATION |
2 |
0.0012 |
| 98 |
EXPOSURE TO SARS-COV-2 |
2 |
0.0012 |
| 99 |
ADENOMA BENIGN |
1 |
0.0012 |
| 100 |
HEPATIC ENZYME INCREASED |
78 |
0.0011 |
| 101 |
FOOD REFUSAL |
1 |
0.0011 |
| 102 |
ASPARTATE AMINOTRANSFERASE INCREASED |
59 |
0.0011 |
| 103 |
LIGAMENT DISORDER |
1 |
0.0011 |
| 104 |
ALANINE AMINOTRANSFERASE INCREASED |
67 |
0.0011 |
| 105 |
VITAMIN D DECREASED |
9 |
0.0011 |
| 106 |
PRODUCT AFTER TASTE |
1 |
0.0010 |
| 107 |
INTUSSUSCEPTION |
1 |
0.0010 |
| 108 |
SKIN TEXTURE ABNORMAL |
1 |
0.0010 |
| 109 |
UNDERWEIGHT |
2 |
0.0010 |
| 110 |
PREMATURE DELIVERY |
16 |
0.0010 |
| 111 |
VARICES OESOPHAGEAL |
3 |
0.0010 |
| 112 |
CHANGE OF BOWEL HABIT |
2 |
0.0010 |
| 113 |
THYROID HORMONES INCREASED |
1 |
0.0010 |
| 114 |
GALLBLADDER ENLARGEMENT |
1 |
0.0009 |
| 115 |
CRYPTORCHISM |
1 |
0.0009 |
| 116 |
MOANING |
1 |
0.0009 |
| 117 |
RESPIRATORY TRACT INFECTION VIRAL |
2 |
0.0009 |
| 118 |
TRANSPLANT |
2 |
0.0008 |
| 119 |
FULL BLOOD COUNT INCREASED |
1 |
0.0008 |
| 120 |
MAGNETIC RESONANCE IMAGING ABNORMAL |
1 |
0.0008 |
| 121 |
BILE DUCT STENOSIS |
1 |
0.0008 |
| 122 |
DYSPLASIA |
1 |
0.0008 |
| 123 |
PRETERM PREMATURE RUPTURE OF MEMBRANES |
1 |
0.0008 |
| 124 |
FAECES SOFT |
6 |
0.0008 |
| 125 |
OTITIS EXTERNA |
1 |
0.0008 |
| 126 |
PRESCRIBED UNDERDOSE |
16 |
0.0008 |
| 127 |
RENAL ATROPHY |
1 |
0.0008 |
| 128 |
BLOOD BILIRUBIN ABNORMAL |
1 |
0.0008 |
| 129 |
GESTATIONAL HYPERTENSION |
1 |
0.0008 |
| 130 |
RHINOVIRUS INFECTION |
3 |
0.0008 |
| 131 |
FAILURE TO THRIVE |
4 |
0.0008 |
| 132 |
LIP INJURY |
1 |
0.0008 |
| 133 |
STEATORRHOEA |
2 |
0.0007 |
| 134 |
SKIN DEPIGMENTATION |
1 |
0.0007 |
| 135 |
BLOOD PHOSPHORUS INCREASED |
2 |
0.0007 |
| 136 |
ABNORMAL FAECES |
6 |
0.0007 |
| 137 |
RENAL ARTERY STENOSIS |
1 |
0.0007 |
| 138 |
NASAL DISCHARGE DISCOLOURATION |
1 |
0.0007 |
| 139 |
DIABETIC METABOLIC DECOMPENSATION |
1 |
0.0007 |
| 140 |
STREPTOCOCCAL INFECTION |
4 |
0.0007 |
| 141 |
INTENSIVE CARE |
1 |
0.0007 |
| 142 |
PULMONARY VALVE INCOMPETENCE |
1 |
0.0007 |
| 143 |
PRURITUS |
258 |
0.0007 |
| 144 |
STOMA SITE HAEMORRHAGE |
1 |
0.0006 |
| 145 |
FAECES DISCOLOURED |
14 |
0.0006 |
| 146 |
YELLOW SKIN |
3 |
0.0006 |
| 147 |
TRANSCRIPTION MEDICATION ERROR |
1 |
0.0006 |
| 148 |
SKULL FRACTURE |
1 |
0.0006 |
| 149 |
PULMONARY ARTERIAL PRESSURE INCREASED |
1 |
0.0006 |
| 150 |
EDUCATIONAL PROBLEM |
1 |
0.0006 |
| 151 |
HEPATIC ENZYME ABNORMAL |
3 |
0.0006 |
| 152 |
SKIN WOUND |
1 |
0.0006 |
| 153 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
3 |
0.0006 |
| 154 |
OTORRHOEA |
1 |
0.0006 |
| 155 |
LIVER FUNCTION TEST INCREASED |
12 |
0.0006 |
| 156 |
LIVER TRANSPLANT REJECTION |
1 |
0.0006 |
| 157 |
NARCOLEPSY |
1 |
0.0005 |
| 158 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 159 |
HEPATIC MASS |
1 |
0.0005 |
| 160 |
FAECES HARD |
2 |
0.0005 |
| 161 |
EPIGASTRIC DISCOMFORT |
2 |
0.0005 |
| 162 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 163 |
CHOLANGITIS |
3 |
0.0005 |
| 164 |
LIVER FUNCTION TEST ABNORMAL |
14 |
0.0005 |
| 165 |
INSURANCE ISSUE |
7 |
0.0005 |
| 166 |
INFUSION SITE INFECTION |
1 |
0.0004 |
| 167 |
POST PROCEDURAL HAEMORRHAGE |
5 |
0.0004 |
| 168 |
DIARRHOEA HAEMORRHAGIC |
4 |
0.0004 |
| 169 |
SPLENOMEGALY |
5 |
0.0004 |
| 170 |
SKIN ABRASION |
2 |
0.0004 |
| 171 |
VIRAL INFECTION |
14 |
0.0004 |
| 172 |
VARICELLA |
1 |
0.0004 |
| 173 |
CHOLESTASIS |
8 |
0.0004 |
| 174 |
EAR INFECTION |
11 |
0.0004 |
| 175 |
HEPATOCELLULAR CARCINOMA |
3 |
0.0004 |
| 176 |
LOW DENSITY LIPOPROTEIN INCREASED |
3 |
0.0004 |
| 177 |
HERNIA REPAIR |
1 |
0.0004 |
| 178 |
PRODUCT USE COMPLAINT |
6 |
0.0004 |
| 179 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 180 |
HEPATIC FAILURE |
11 |
0.0004 |
| 181 |
HYPERKERATOSIS |
2 |
0.0004 |
| 182 |
PRESCRIBED OVERDOSE |
7 |
0.0004 |
| 183 |
TRANSAMINASES INCREASED |
8 |
0.0004 |
| 184 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 185 |
PREMATURE LABOUR |
2 |
0.0004 |
| 186 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 187 |
CARDIAC OPERATION |
3 |
0.0003 |
| 188 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 189 |
UPPER RESPIRATORY TRACT CONGESTION |
1 |
0.0003 |
| 190 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 191 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 192 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
3 |
0.0003 |
| 193 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 194 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 195 |
DYSCHEZIA |
1 |
0.0003 |
| 196 |
FRACTURE |
6 |
0.0003 |
| 197 |
LISTLESS |
1 |
0.0003 |
| 198 |
APPETITE DISORDER |
2 |
0.0003 |
| 199 |
PEPTIC ULCER |
1 |
0.0003 |
| 200 |
PRODUCT TASTE ABNORMAL |
4 |
0.0003 |
| 201 |
DEFAECATION URGENCY |
2 |
0.0003 |
| 202 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 203 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 204 |
INTERNATIONAL NORMALISED RATIO INCREASED |
8 |
0.0003 |
| 205 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 206 |
INTENTIONAL UNDERDOSE |
2 |
0.0003 |
| 207 |
LABORATORY TEST ABNORMAL |
8 |
0.0003 |
| 208 |
WOUND HAEMORRHAGE |
1 |
0.0003 |
| 209 |
MALNUTRITION |
3 |
0.0003 |
| 210 |
POLYDIPSIA |
1 |
0.0003 |
| 211 |
INTRACRANIAL ANEURYSM |
1 |
0.0002 |
| 212 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 213 |
HEPATIC PAIN |
1 |
0.0002 |
| 214 |
HEPATIC LESION |
1 |
0.0002 |
| 215 |
HORDEOLUM |
1 |
0.0002 |
| 216 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 217 |
LIVER DISORDER |
10 |
0.0002 |
| 218 |
THERAPY INTERRUPTED |
16 |
0.0002 |
| 219 |
HEAVY MENSTRUAL BLEEDING |
2 |
0.0002 |
| 220 |
DEVELOPMENTAL DELAY |
2 |
0.0002 |
| 221 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 222 |
URINE ABNORMALITY |
1 |
0.0002 |
| 223 |
RHINORRHOEA |
14 |
0.0002 |
| 224 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 225 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 226 |
HEPATIC FUNCTION ABNORMAL |
8 |
0.0002 |
| 227 |
TIBIA FRACTURE |
1 |
0.0002 |
| 228 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 229 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 230 |
INCREASED APPETITE |
4 |
0.0002 |
| 231 |
RASH VESICULAR |
1 |
0.0002 |
| 232 |
THERAPY CHANGE |
2 |
0.0002 |
| 233 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 234 |
MATERNAL EXPOSURE DURING PREGNANCY |
18 |
0.0002 |
| 235 |
GASTROINTESTINAL SOUNDS ABNORMAL |
1 |
0.0002 |
| 236 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 237 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 238 |
PREMATURE BABY |
6 |
0.0002 |
| 239 |
FEEDING DISORDER |
4 |
0.0002 |
| 240 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 241 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 242 |
ANAL ABSCESS |
1 |
0.0002 |
| 243 |
NASOPHARYNGITIS |
34 |
0.0002 |
| 244 |
PRODUCT DOSE OMISSION IN ERROR |
5 |
0.0002 |
| 245 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 246 |
GASTROENTERITIS VIRAL |
3 |
0.0002 |
| 247 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 248 |
ILLNESS |
17 |
0.0002 |
| 249 |
TREATMENT NONCOMPLIANCE |
9 |
0.0002 |
| 250 |
INGUINAL HERNIA |
1 |
0.0002 |
| 251 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 252 |
HAEMATOCHEZIA |
9 |
0.0002 |
| 253 |
MIDDLE INSOMNIA |
3 |
0.0002 |
| 254 |
HEPATIC CIRRHOSIS |
3 |
0.0002 |
| 255 |
HAEMATEMESIS |
4 |
0.0002 |
| 256 |
DIARRHOEA |
101 |
0.0002 |
| 257 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 258 |
HEPATITIS ACUTE |
1 |
0.0002 |
| 259 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 260 |
BLOOD CHOLESTEROL INCREASED |
7 |
0.0002 |
| 261 |
CHOLECYSTITIS CHRONIC |
1 |
0.0001 |
| 262 |
ABDOMINAL DISCOMFORT |
25 |
0.0001 |
| 263 |
FREQUENT BOWEL MOVEMENTS |
4 |
0.0001 |
| 264 |
ECCHYMOSIS |
1 |
0.0001 |
| 265 |
ABDOMINAL PAIN UPPER |
30 |
0.0001 |
| 266 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 267 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 268 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 269 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 270 |
PAPULE |
1 |
0.0001 |
| 271 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 272 |
HAND FRACTURE |
1 |
0.0001 |
| 273 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 274 |
ABDOMINAL PAIN |
32 |
0.0001 |
| 275 |
OFF LABEL USE |
120 |
0.0001 |
| 276 |
ACCIDENTAL OVERDOSE |
5 |
0.0001 |
| 277 |
ASCITES |
4 |
0.0001 |
| 278 |
ARTHROPOD BITE |
1 |
0.0001 |
| 279 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 280 |
CHROMATURIA |
3 |
0.0001 |
| 281 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 282 |
LIPASE INCREASED |
1 |
0.0001 |
| 283 |
UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 284 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 285 |
RENAL CYST |
1 |
0.0001 |
| 286 |
PRODUCT DOSE OMISSION ISSUE |
36 |
0.0001 |
| 287 |
LIVER INJURY |
3 |
0.0001 |
| 288 |
CHOLELITHIASIS |
4 |
0.0001 |
| 289 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 290 |
COAGULOPATHY |
2 |
0.0001 |
| 291 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 292 |
MUSCLE STRAIN |
1 |
0.0001 |
| 293 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 294 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 295 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 296 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 297 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 298 |
INFLUENZA |
12 |
0.0001 |
| 299 |
WOUND |
3 |
0.0001 |
| 300 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 301 |
APPENDICITIS |
1 |
0.0001 |
| 302 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 303 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 304 |
FLATULENCE |
6 |
0.0001 |
| 305 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 306 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 307 |
HEPATOMEGALY |
1 |
0.0001 |
| 308 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 309 |
UPPER LIMB FRACTURE |
2 |
0.0001 |
| 310 |
WEIGHT INCREASED |
22 |
0.0001 |
| 311 |
SLUGGISHNESS |
1 |
0.0001 |
| 312 |
EAR DISCOMFORT |
1 |
0.0001 |
| 313 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 314 |
COUGH |
27 |
0.0001 |
| 315 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 316 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 317 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 318 |
RETCHING |
2 |
0.0001 |
| 319 |
SKIN LACERATION |
1 |
0.0001 |
| 320 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 321 |
DENTAL CARIES |
1 |
0.0001 |
| 322 |
RASH PAPULAR |
2 |
0.0001 |
| 323 |
SNEEZING |
2 |
0.0001 |
| 324 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 325 |
VOMITING |
41 |
0.0001 |
| 326 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 327 |
FOETAL EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
| 328 |
DECREASED APPETITE |
20 |
0.0001 |
| 329 |
COVID-19 |
15 |
0.0001 |
| 330 |
NASAL CONGESTION |
5 |
0.0001 |
| 331 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 332 |
CRYING |
3 |
0.0001 |
| 333 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 334 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 335 |
EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 336 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 337 |
HEPATIC CYTOLYSIS |
1 |
0.0001 |
| 338 |
SKIN ULCER |
2 |
0.0001 |
| 339 |
HAEMATOMA |
2 |
0.0001 |
| 340 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 341 |
NODULE |
1 |
0.0001 |
| 342 |
HAEMORRHAGE |
8 |
0.0001 |
| 343 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 344 |
ADVERSE REACTION |
1 |
0.0001 |
| 345 |
SINUS CONGESTION |
1 |
0.0001 |
| 346 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 347 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 348 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 349 |
GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0001 |
| 350 |
MASS |
1 |
0.0001 |
| 351 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 352 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 353 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 354 |
INSOMNIA |
18 |
0.0001 |
| 355 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 356 |
PYREXIA |
23 |
0.0001 |
| 357 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 358 |
FEMUR FRACTURE |
2 |
0.0001 |
| 359 |
PRODUCT USE ISSUE |
12 |
0.0001 |
| 360 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 361 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 362 |
DRUG INEFFECTIVE |
83 |
0.0001 |
| 363 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 364 |
ABSCESS |
1 |
0.0001 |
| 365 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 366 |
EYE PRURITUS |
2 |
0.0001 |
| 367 |
PERICARDITIS |
1 |
0.0001 |
| 368 |
CONDITION AGGRAVATED |
18 |
0.0001 |
| 369 |
ECZEMA |
3 |
0.0001 |
| 370 |
GASTROINTESTINAL DISORDER |
5 |
0.0001 |
| 371 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 372 |
EPISTAXIS |
4 |
0.0001 |
| 373 |
PROTEINURIA |
1 |
0.0001 |
| 374 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 375 |
LETHARGY |
3 |
0.0001 |
| 376 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 377 |
HERNIA |
1 |
0.0001 |
| 378 |
HAEMORRHOIDS |
1 |
0.0001 |
| 379 |
CHOKING |
1 |
0.0001 |
| 380 |
DISEASE PROGRESSION |
6 |
0.0001 |
| 381 |
CONSTIPATION |
11 |
0.0001 |
| 382 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 383 |
SINUSITIS |
5 |
0.0000 |
| 384 |
EATING DISORDER |
1 |
0.0000 |
| 385 |
WEIGHT DECREASED |
13 |
0.0000 |
| 386 |
SWELLING FACE |
3 |
0.0000 |
| 387 |
MELAENA |
1 |
0.0000 |
| 388 |
ORAL PAIN |
1 |
0.0000 |
| 389 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 390 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 391 |
SHOCK |
1 |
0.0000 |
| 392 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 393 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 394 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 395 |
PRESYNCOPE |
1 |
0.0000 |
| 396 |
DYSGEUSIA |
3 |
0.0000 |
| 397 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 398 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 399 |
HYPOPHAGIA |
1 |
0.0000 |
| 400 |
DEHYDRATION |
5 |
0.0000 |
| 401 |
PAIN OF SKIN |
1 |
0.0000 |
| 402 |
RASH PRURITIC |
2 |
0.0000 |
| 403 |
OEDEMA |
2 |
0.0000 |
| 404 |
SEPSIS |
4 |
0.0000 |
| 405 |
HYPERSOMNIA |
1 |
0.0000 |
| 406 |
DYSSTASIA |
1 |
0.0000 |
| 407 |
IRRITABILITY |
2 |
0.0000 |
| 408 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 409 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 410 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 411 |
HEAD INJURY |
1 |
0.0000 |
| 412 |
MIGRAINE |
3 |
0.0000 |
| 413 |
MOOD SWINGS |
1 |
0.0000 |
| 414 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 415 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 416 |
EYE DISORDER |
1 |
0.0000 |
| 417 |
SKIN DISORDER |
1 |
0.0000 |
| 418 |
DRY SKIN |
4 |
0.0000 |
| 419 |
URTICARIA |
5 |
0.0000 |
| 420 |
RASH |
13 |
0.0000 |
| 421 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 422 |
SLEEP DISORDER |
2 |
0.0000 |
| 423 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 424 |
NAUSEA |
22 |
0.0000 |
| 425 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 426 |
RESTLESSNESS |
1 |
0.0000 |
| 427 |
EYE SWELLING |
1 |
0.0000 |
| 428 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 429 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 430 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 431 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 432 |
CARDIAC ARREST |
2 |
0.0000 |
| 433 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 434 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 435 |
BALANCE DISORDER |
2 |
0.0000 |
| 436 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 437 |
MENTAL DISORDER |
1 |
0.0000 |
| 438 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 439 |
MALAISE |
10 |
0.0000 |
| 440 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 441 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 442 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 443 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 444 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 445 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 446 |
CONTUSION |
2 |
0.0000 |
| 447 |
THERAPY CESSATION |
1 |
0.0000 |
| 448 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 449 |
INFLAMMATION |
1 |
0.0000 |
| 450 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 451 |
DEPRESSED MOOD |
1 |
0.0000 |
| 452 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 453 |
PNEUMONIA |
6 |
0.0000 |
| 454 |
MEDICATION ERROR |
1 |
0.0000 |
| 455 |
ASTHMA |
2 |
0.0000 |
| 456 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 457 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 458 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 459 |
DISCOMFORT |
1 |
0.0000 |
| 460 |
AMNESIA |
1 |
0.0000 |
| 461 |
RENAL FAILURE |
2 |
0.0000 |
| 462 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 463 |
SOMNOLENCE |
3 |
0.0000 |
| 464 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 465 |
OVERDOSE |
3 |
0.0000 |
| 466 |
INFECTION |
2 |
0.0000 |
| 467 |
UNDERDOSE |
1 |
0.0000 |
| 468 |
AGITATION |
1 |
0.0000 |
| 469 |
DEPRESSION |
3 |
0.0000 |
| 470 |
HOSPITALISATION |
2 |
0.0000 |
| 471 |
PARAESTHESIA |
2 |
0.0000 |
| 472 |
CARDIAC FAILURE |
1 |
0.0000 |
| 473 |
THROMBOSIS |
1 |
0.0000 |
| 474 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 475 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 476 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 477 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 478 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 479 |
HEADACHE |
7 |
0.0000 |
| 480 |
MUSCLE SPASMS |
2 |
0.0000 |
| 481 |
CARDIAC DISORDER |
1 |
0.0000 |
| 482 |
ANAEMIA |
2 |
0.0000 |
| 483 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 484 |
FATIGUE |
8 |
0.0000 |
| 485 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 486 |
DIZZINESS |
5 |
0.0000 |
| 487 |
SYNCOPE |
1 |
0.0000 |
| 488 |
PAIN |
6 |
0.0000 |
| 489 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 490 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 491 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 492 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 493 |
ANXIETY |
2 |
0.0000 |
| 494 |
DEATH |
6 |
0.0000 |
| 495 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 496 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 497 |
FALL |
2 |
0.0000 |
| 498 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 499 |
CHEST PAIN |
1 |
0.0000 |
| 500 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 501 |
ASTHENIA |
2 |
0.0000 |
| 502 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 503 |
ALOPECIA |
1 |
0.0000 |
| 504 |
ARTHRALGIA |
2 |
0.0000 |
| 505 |
FEELING ABNORMAL |
1 |
0.0000 |
| 506 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 507 |
DYSPNOEA |
1 |
0.0000 |